SCHEMBL5962354

SCHEMBL5962354

Cc1cccc(Nc2nccc(-c3nc(C4(N)CCCCC4)[nH]c3-c3ccc(F)cc3)n2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.47
PIK3CG P48736 3/20 0.47
ABL1 P00519 2/20 0.45
BCR P11274 2/20 0.45
CDK2 P24941 4/20 0.42
SRC P12931 1/20 0.42
ZAP70 P43403 1/20 0.42
SYK P43405 1/20 0.42
CDK1 P06493 2/20 0.42
CCNB2 O95067 1/20 0.42
RET P07949 1/20 0.42
CCNB1 P14635 1/20 0.42
CCNB3 Q8WWL7 1/20 0.42
GSK3B P49841 2/20 0.42
BRD4 O60885 2/20 0.41
BRD2 P25440 2/20 0.41
BRD3 Q15059 2/20 0.41
MAPK14 Q16539 2/20 0.41
BRDT Q58F21 2/20 0.41
EIF2AK2 P19525 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5962311 0.79 MAPK14 (0.51) GSK3BMAPK14DYRK1A
SCHEMBL5962308 0.79 MAPK14 (0.51) GSK3BMAPK14DYRK1A
SCHEMBL4114860 0.72 EIF2AK2 (0.54) PIK3CAPIK3CGABL1CDK2GSK3B
SCHEMBL5962480 0.70 MAPK13 (0.56) GSK3BBRD4MAPK14BRDT
SCHEMBL4052951 0.67 MAPK13 (0.79) MAPK14
SCHEMBL7467324 0.65 ABL1 (0.76) PIK3CAPIK3CGABL1BCRCDK2
SCHEMBL7486308 0.65 EIF2AK2 (0.52) PIK3CAPIK3CGCDK2GSK3BMAPK14
SCHEMBL2322043 0.64 PIK3CG (0.70) PIK3CAPIK3CGABL1BCRCDK2
SCHEMBL2331086 0.64 PIK3CG (0.70) PIK3CAPIK3CGABL1BCRCDK2
SCHEMBL4544813 0.64 NFKB1 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1232153-A2 IMIDAZOLE DERIVATIVES AND THEIR USE AS RAF KINASE INHIBITORS SMITHKLINE BEECHAM PLC (GB) 2002-08-21 EP claimed
WO-2001038324-A2 IMIDAZOLE DERIVATIVES AND THEIR USE AS RAF KINASE INHIBITORS SMITHKLINE BEECHAM P.L.C. (GB) 2001-05-31 WO claimed
US-7026336-B1 4-pyridinylimidazol-2-ylhydrocarbyl amine, (thio)urea, carbamic acid or sulfonamide derivatives, e.g., (2-(4-(4-Chloro-3-methoxy-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl)-2-methyl-propyl)-carbamic acid tert-butyl ester; Raf kinase inhibitors for the treatment of neurotraumatic diseases SMITHKLINE BEECHAM P.L.C. (GB) 2006-04-11 US disclosed
EP-1232153-B1 IMIDAZOLE DERIVATIVES AND THEIR USE AS RAF KINASE INHIBITORS SMITHKLINE BEECHAM PLC (GB) 2004-11-03 EP disclosed
EP-1232153-A2 IMIDAZOLE DERIVATIVES AND THEIR USE AS RAF KINASE INHIBITORS SMITHKLINE BEECHAM PLC (GB) 2002-08-21 EP disclosed
WO-2001038324-A2 IMIDAZOLE DERIVATIVES AND THEIR USE AS RAF KINASE INHIBITORS SMITHKLINE BEECHAM P.L.C. (GB) 2001-05-31 WO disclosed